Skip to content
DataLookout
Menu

TDSNCT06744049

Transfer Direct System as a New Method for Embryo Transfer

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 12 words
    • Study sites: 4 to 5
    • Study description expanded, about 10 words
  2. Minor Site details revised at 1 of 4 sitesv4
  3. Notable Primary completion date: Aug 2025 to Dec 2026
    • Study sites: 3 to 4
    • Study completion date: Aug 2025 to Mar 2027
    v3
  4. Minor Study sites: 2 to 3
    • Primary completion date: Jun 2025 to Aug 2025
    v2
  5. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Safety of TDS in comparison with conventional transfer
Timeframe: From enrollment to final study visit at 8-10 weeks of pregnancy

Secondary (4)

Efficacy and non-inferiority of TDS
pregnancy rate
ongoing gestation rate
miscarriage rate

Arms and interventions

Embryo transfer with Transfer Direct System (TDS)Experimental

The trial has a single assignment group aimed at patients of reproductive age who attend the clinic with a desire for a child and undergo Assisted Reproduction Treatment (ART) with an euploid single embryo transfer (SET) after corresponding hormone replacement therapy (HRT) has been carried out.

Devices: Transfer Direct System (TDS)

Sites

5 sites in 1 country